Login

Janelle Tibbetts, owner, expresses empowerment in controlling her usage thanks to Caribbean Utilities Company Ltd. 00:10:00

Share On Facebook Share On Twitter

Richard Hew, CUC's President and Chief Executive Officer.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
A video message from American Water's CEO Walter Lynch addresses customers and communities.
00:10:00
Evaluating Privacy in Cryptocurrencies|Jordan Clifford,Co-Founder and Managing Director,Scalar Capital
00:10:00
Cracking the ESG Code: Insights from Leaders in Quantitative Investing | Bloomberg Invest Summit Panelists
00:00:00
Jonathan N. Johnson, M.D. Pediatric Cardiologist, Mayo Clinic / Mayo Clinic Explains Congenital Heart Defects
00:10:00
Insight Partners has helped over so many companies turn their vision into reality|Thilo Semmelbauer,Managing Director,Insight Partners
00:10:00
Q3 Results Interview with CEO of Eastnine | Kestutis Sasnauskas, CEO, Eastnine AB.
00:10:00
Darwin Green Discusses High-Grade Gold Projects and Strategic Developments at HighGold Mining
00:10:00
"Meet the Manager: Shane Hurst on Navigating Global Trends in Infrastructure Investment" | Shane Hurst - Managing Director and Portfolio Manager of the Legg Mason
00:10:00
Maximizing Social Security Benefits | Mark Schweiss, CFP®, CFA, CPA | Modern Dollar Planning
00:10:00
Market History & Financial Planning with George Smith | George Smith, co-CEO and Chief Investment Officer of Smith Bruer Advisors
00:10:00
Desjardins Group's Strong Performance and Commitment to Social Responsibility | Guy Cormier, CEO ,   Desjardins Group.
00:00:00
ONCIMMUNE HOLDINGS PLC - Strategy Update - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings

© 2026 Nehu